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Background
The risk of heart failure in obesity and type 2 diabetes is
greater than can be accounted for by hypertension and
coronary artery disease. Rodent studies indicate that in
obesity and type 2 diabetes, lipid over-storage in cardiac
myocytes produces lipotoxic intermediates leading to
heart failure. Cardiac steatosis was previously demon-
strated in explanted hearts of patients with end-stage
nonischemic cardiomyopathy. We demonstrated that car-
diac steatosis precedes the onset of cardiomyopathy in
individuals with impaired glucose tolerance or in patients
with type 2 diabetes mellitus using 1.5 T MR system. To
perform cardiac MR Spectroscopy studies using 3 Tesla
MRI system we had to overcome the particular chal-
lenges at high magnetic field.
Methods
Localized spectroscopy can distinguish between triglycer-
ide droplets localized in the cytosol of cardiomyocytes
(i.e. an aqueous microenvironment) and triglycerides
stored in adipocytes (i.e. a lipid microenvironment). Dur-
ing 1H-MRS, these different microenvironments cause
triglycerides to resonate at different frequencies. In this
study to determine myocardial triglyceride content we
used a 3-Tesla Verio whole-body system (Siemens)
equipped with spectroscopy and cardiac packages allow-
ing for compensation of respiratory motion (PACE) and
cardiac motion ( Siemens Work in Progress package).
We positioned the spectroscopic volume of interest
within bi-ventricular septum using the end-systolic cine
images in 3 planes, collected as patients held their breath
at the end of expiration. During acquisition of spectro-
scopic data, patients breathed freely. The spectroscopic
signal was acquired with cardiac triggering at the end of
systole and with respiratory gating at end expiration. We
used the PRESS sequence (Point-RESolved Spectroscopy)
for spatial localization, and the interpulse delay was
defined by the length of a respiratory cycle (≈4 seconds).
Results
After careful setup to compensate and to synchronize
respiratory and cardiac motion we were able to collect
high quality cardiac magnetic resonance spectra at 3
Tesla in humans in vivo. We recognized advantages of
high field such as: 1) enhanced spectral intensity allow-
ing using smaller volume of interest and shorter period
for data collection; and 2) better spatial resolution of
resonances. However, for a successful data collection the
motion compensation had to be nearly perfect. This
requirement sometimes presents an enormous challenge.
Conclusions
Cardiac spectroscopy at 3 Tesla presents usual advan-
tages such as enhanced spectral intensity and spatial
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